These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30718967)

  • 1. Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension.
    Jhawat V; Gupta S; Agarwal BK; Roy P; Saini V
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551418825037. PubMed ID: 30718967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension.
    Gupta S; Jhawat V; Agarwal BK; Roy P; Saini V
    Curr Hypertens Rev; 2019; 15(2):123-134. PubMed ID: 30062972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of insertion/deletion polymorphism in angiotensin-converting enzyme gene with hypertensive type 2 diabetes mellitus].
    Zhou L; Xue YM; Luo R; Gao F
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):808-10. PubMed ID: 12297438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension.
    Mondorf UF; Russ A; Wiesemann A; Herrero M; Oremek G; Lenz T
    Am J Hypertens; 1998 Feb; 11(2):174-83. PubMed ID: 9524045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme insertion/deletion polymorphism association with obesity and some related disorders in Egyptian females: a case-control observational study.
    Motawi TK; Shaker OG; Shahin NN; Ahmed NM
    Nutr Metab (Lond); 2016; 13():68. PubMed ID: 27777603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of angiotensin converting enzyme gene insertion/deletion polymorphism on anthropometric and biochemical parameters among hypertension patients: A case-control study from Northwest Ethiopia.
    Birhan TA; Molla MD; Tesfa KH
    PLoS One; 2023; 18(5):e0285618. PubMed ID: 37200278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme gene I/D polymorphism increases the susceptibility to hypertension and additive diseases: A study on North Indian patients.
    Singh M; Singh AK; Singh S; Pandey P; Chandra S; Gambhir IS
    Clin Exp Hypertens; 2016; 38(3):305-11. PubMed ID: 27030424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression.
    Fildes JE; Walker AH; Densem CG; Deiraniya AK; Hutchinson IV; Leonard CT; Yonan N
    J Heart Lung Transplant; 2005 Apr; 24(4):406-10. PubMed ID: 15797740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis.
    Fernández-Llama P; Poch E; Oriola J; Botey A; Coll E; Darnell A; Rivera F; Revert L
    Kidney Int; 1998 Jun; 53(6):1743-7. PubMed ID: 9607207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.
    Hristova M; Stanilova S; Miteva L
    Clin Exp Hypertens; 2019; 41(7):662-669. PubMed ID: 30307755
    [No Abstract]   [Full Text] [Related]  

  • 11. GNB3 gene C825T and ACE gene I/D polymorphisms in essential hypertension in a Kazakh genetic isolate.
    Wang X; Wang S; Lin R; Jiang X; Cheng Z; Turdi J; Ding J; Wu G; Lu X; Wen H
    J Hum Hypertens; 2004 Sep; 18(9):663-8. PubMed ID: 15042113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients.
    Yu H; Zhang Y; Liu G
    Hypertens Res; 2003 Nov; 26(11):881-6. PubMed ID: 14714579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population.
    Gesang L; Liu G; Cen W; Qiu C; Zhuoma C; Zhuang L; Ren D; Pincuo Z; Chan Y
    Hypertens Res; 2002 May; 25(3):481-5. PubMed ID: 12135330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin angiotensin system blockage associates with insertion/deletion polymorphism of angiotensin-converting enzyme in patients with hypertensive emergency.
    Vilela-Martin JF; Vaz-de-Melo RO; Cosenso-Martin LN; Kuniyoshi CH; Yugar-Toledo JC; Pinhel MA; de Souza GF; Souza DR; Pimenta E; Moreno H; Cipullo JP
    DNA Cell Biol; 2013 Sep; 32(9):541-8. PubMed ID: 23869738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population.
    Krishnan R; Sekar D; Karunanithy S; Subramanium S
    Genes Dis; 2016 Jun; 3(2):159-163. PubMed ID: 30258884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
    Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
    Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset diabetes and antihypertensive treatment.
    Grimm C; Köberlein J; Wiosna W; Kresimon J; Kiencke P; Rychlik R
    GMS Health Technol Assess; 2010 Mar; 6():Doc03. PubMed ID: 21289876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.